ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.7252_7253AG[1] (p.Arg2418fs) (rs80359644)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000574102 SCV000665941 pathogenic Hereditary cancer-predisposing syndrome 2016-12-07 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Breast Cancer Information Core (BIC) (BRCA2) RCV000113741 SCV000147062 pathogenic Breast-ovarian cancer, familial 2 1999-06-22 no assertion criteria provided clinical testing
Color RCV000574102 SCV000683859 pathogenic Hereditary cancer-predisposing syndrome 2017-05-29 criteria provided, single submitter clinical testing
Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge RCV000113741 SCV000327621 pathogenic Breast-ovarian cancer, familial 2 2015-10-02 criteria provided, single submitter clinical testing
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000113741 SCV000301147 pathogenic Breast-ovarian cancer, familial 2 2016-09-08 reviewed by expert panel curation Variant allele predicted to encode a truncated non-functional protein.
GeneDx RCV000220840 SCV000279439 pathogenic not provided 2016-07-19 criteria provided, single submitter clinical testing This deletion of 2 nucleotides in BRCA2 is denoted c.7254_7255delAG at the cDNA level and p.Arg2418SerfsX2 (R2418SfsX2) at the protein level. Using alternate nomenclature, this variant has been reported as BRCA2 7482delAG. The normal sequence, with the bases that are deleted in braces, is ACAG[AG]TTGA. The deletion causes a frameshift, which changes an Arginine to a Serine at codon 2418, and creates a premature stop codon at position 2 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. BRCA2 c.7254_7255delAG has been reported in association with early onset breast cancer in a Nigerian patient (Fackenthal 2012). We consider this variant to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.